share_log

ESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM) | SC 13D: Statement of acquisition of beneficial ownership by individuals-Eureka Therapeutics, Inc.(71.8%)

ESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM) | SC 13D:超過5%持股股東披露文件-Eureka Therapeutics, Inc.(71.8%)

美股sec公告 ·  2023/10/27 19:27
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息